Your browser doesn't support javascript.
loading
Differences in right ventricular function and response to targeted therapy between patients with IPAH and PAH-CHD.
Zhu, Tengteng; Wu, Panyun; Tan, Zhen; Jin, Quan; Chen, Yusi; Li, Lian; Chen, Zewei; Tang, Yirui; Li, Jiang; Fang, Zhenfei.
  • Zhu T; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Wu P; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Tan Z; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Jin Q; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Chen Y; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Li L; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Chen Z; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Tang Y; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Li J; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Fang Z; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Front Pharmacol ; 14: 1124746, 2023.
Article en En | MEDLINE | ID: mdl-36860300